BMY:NYE-Bristol-Myers Squibb Company (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 52.66

Change

+0.16 (+0.30)%

Market Cap

USD 106.76B

Volume

9.65M

Analyst Target

USD 73.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey. Address: Route 206 & Province Line Road, Princeton, NJ, United States, 08543

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

-56.75 (-6.28%)

USD 813.31B
NVO Novo Nordisk A/S

+1.26 (+1.13%)

USD 513.37B
JNJ Johnson & Johnson

+0.52 (+0.32%)

USD 399.33B
ABBV AbbVie Inc

+12.05 (+6.36%)

USD 335.04B
PFE Pfizer Inc

+0.06 (+0.21%)

USD 163.54B
OGN Organon & Co

+0.08 (+0.45%)

USD 4.47B
GSK GlaxoSmithKline PLC ADR

-1.16 (-3.04%)

N/A
MRK Merck & Company Inc

+1.10 (+1.06%)

N/A
NVS Novartis AG ADR

-0.62 (-0.56%)

N/A

ETFs Containing BMY

FHI:CA CI Health Care Giants Cov.. 5.26 % 0.75 %

+0.02 (+-0.10%)

CAD 0.08B
FHI-B:CA CI Health Care Giants Cov.. 5.26 % 0.00 %

N/A

CAD 0.05B
HHL-U:CA Harvest Healthcare Leader.. 5.04 % 0.00 %

-0.02 (-0.10%)

N/A
HHL-B:CA Harvest Healthcare Leader.. 5.04 % 0.00 %

-0.11 (-0.10%)

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.55 % 0.00 %

-0.04 (-0.10%)

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.49 % 0.00 %

+0.09 (+-0.10%)

N/A
CAMX Cambiar Aggressive Value .. 4.24 % 0.00 %

+0.08 (+-0.10%)

USD 0.06B
MEDX Horizon Kinetics Medical .. 4.15 % 0.00 %

-0.39 (-0.10%)

N/A
SCHD Schwab U.S. Dividend Equi.. 4.08 % 0.07 %

+0.09 (+-0.10%)

USD 63.08B
KNGU:CA Brompton U.S. Cash Flow K.. 4.07 % 0.00 %

-0.01 (-0.10%)

CAD 5.23M
DIVP The Advisors’ Inner .. 3.66 % 0.00 %

-0.12 (-0.10%)

USD 0.01B
LSAT Two Roads Shared Trust - .. 3.40 % 0.00 %

+0.09 (+-0.10%)

USD 0.13B
CDNA:CA CI Bio-Revolution Index E.. 3.17 % 0.00 %

N/A

CAD 6.10M
USMV:LSE Ossiam US Minimum Varianc.. 3.00 % 0.00 %

-0.53 (-0.10%)

USD 0.01B
MVUS:PA 3.00 % 0.00 %

N/A

N/A
SPMV:PA 3.00 % 0.00 %

N/A

N/A
OSX2:XETRA Ossiam US Minimum Varianc.. 3.00 % 0.00 %

-2.25 (-0.10%)

USD 0.12B
ETLI:XETRA L&G Pharma Breakthrough U.. 2.86 % 0.00 %

-0.12 (-0.10%)

USD 0.02B
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.71 % 0.00 %

-0.25 (-0.10%)

USD 0.01B
MOTU:LSE VanEck Morningstar US Wid.. 2.70 % 0.00 %

+0.08 (+-0.10%)

USD 0.05B
MOTV:LSE VanEck Morningstar US Wid.. 2.69 % 0.00 %

-0.05 (-0.10%)

USD 0.05B
WTD9:F WisdomTree US Equity Inco.. 2.68 % 0.00 %

-0.09 (-0.10%)

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.68 % 0.00 %

-0.11 (-0.10%)

USD 0.99M
WTEU:F WisdomTree US Equity Inco.. 2.68 % 0.00 %

-0.23 (-0.10%)

USD 0.11B
WTD9:XETRA WisdomTree Issuer ICAV - .. 2.68 % 0.00 %

-0.07 (-0.10%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 2.68 % 0.00 %

-0.02 (-0.10%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 2.68 % 0.00 %

-0.07 (-0.10%)

USD 0.11B
SPHD Invesco S&P 500® High Di.. 2.66 % 0.30 %

+0.14 (+-0.10%)

USD 3.45B
HEAL:CA 2.66 % 0.00 %

N/A

N/A
MOAT:AU VanEck Morningstar Wide M.. 2.64 % 0.00 %

+0.01 (+-0.10%)

USD 0.98B
HDLV:PA Invesco S&P 500 High Divi.. 2.60 % 0.00 %

-0.23 (-0.10%)

USD 0.51B
HDLV:XETRA Invesco S&P 500 High Divi.. 2.60 % 0.00 %

-0.22 (-0.10%)

USD 0.31B
HDCH:SW Invesco S&P 500 High Divi.. 2.60 % 0.00 %

-0.34 (-0.10%)

USD 4.38M
MHOT:AU VanEck Morningstar Wide M.. 2.59 % 0.00 %

N/A

N/A
TDGB:LSE VanEck Morningstar Develo.. 2.58 % 0.00 %

-0.12 (-0.10%)

USD 1.05B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.57 % 0.00 %

-0.10 (-0.10%)

USD 0.07B
VDIV:F VanEck Vectors ETFs N.V... 2.46 % 0.00 %

-0.61 (-0.10%)

USD 0.64B
VDIV:XETRA VanEck Morningstar Develo.. 2.46 % 0.00 %

-0.34 (-0.10%)

USD 0.64B
TDIV:SW VanEck Morningstar Develo.. 2.46 % 0.00 %

-0.20 (-0.10%)

USD 1.07B
DHS:SW WisdomTree US Equity Inco.. 2.39 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.39 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.37 % 0.00 %

-0.06 (-0.10%)

CAD 0.09B
RNDV First Trust US Equity Div.. 2.18 % 0.50 %

-0.06 (-0.10%)

USD 0.04B
SDOG ALPS Sector Dividend Dogs.. 2.10 % 0.40 %

+0.06 (+-0.10%)

USD 1.23B
SPDV AAM S&P 500 High Dividend.. 2.03 % 0.29 %

-0.06 (-0.10%)

USD 0.06B
INCM:AU BetaShares Global Income .. 1.83 % 0.00 %

-0.03 (-0.10%)

USD 0.03B
PUD.B:CA 1.82 % 0.66 %

N/A

N/A
RSPH Invesco S&P 500® Equal.. 1.81 % 0.00 %

+0.07 (+-0.10%)

USD 0.90B
2B78:XETRA iShares Healthcare Innova.. 1.80 % 0.00 %

+0.01 (+-0.10%)

USD 1.14B
2B78:F iShares Healthcare Innova.. 1.80 % 0.00 %

N/A

N/A
UVDV 1.72 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 1.71 % 0.00 %

+0.01 (+-0.10%)

N/A
KVLE KFA Value Line Dynamic Co.. 1.71 % 0.00 %

+0.03 (+-0.10%)

USD 0.03B
ZLU-U:CA BMO Low Volatility US Equ.. 1.65 % 0.00 %

-0.08 (-0.10%)

N/A
ZLU:CA BMO Low Volatility US Equ.. 1.65 % 0.33 %

-0.10 (-0.10%)

CAD 1.86B
EDGE:CA Evolve Innovation Index F.. 1.55 % 0.60 %

+0.08 (+-0.10%)

CAD 0.04B
EDGE-U:CA Evolve Innovation Index F.. 1.55 % 0.00 %

N/A

N/A
DIVG Invesco Exchange-Traded F.. 1.53 % 0.00 %

+0.08 (+-0.10%)

USD 2.85M
UC82:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+1.75 (+-0.10%)

USD 0.07B
UC86:LSE UBS(Lux)Fund Solutions .. 1.35 % 0.00 %

+0.02 (+-0.10%)

USD 0.28B
SPXB 1.32 % 0.15 %

N/A

N/A
UC98:LSE UBS(Lux)Fund Solutions .. 0.74 % 0.00 %

+6.50 (+-0.10%)

USD 0.18B
BSUS:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+4.85 (+-0.10%)

N/A
UC97:LSE UBS(Lux)Fund Solutions .. 0.72 % 0.00 %

+0.09 (+-0.10%)

USD 0.18B
UET0:F UBS (Lux) Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.10 (+-0.10%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.05 (+-0.10%)

N/A
CBSUS:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

+0.12 (+-0.10%)

N/A
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.65 % 0.00 %

N/A

N/A
QUIG:CA Mackenzie US Investment G.. 0.62 % 0.28 %

+0.29 (+-0.10%)

CAD 0.54B
UC76:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+0.09 (+-0.10%)

USD 0.09B
UC85:LSE UBS Barclays US Liquid Co.. 0.53 % 0.00 %

+7.75 (+-0.10%)

USD 0.07B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

-0.13 (-0.10%)

USD 0.01B
DHS WisdomTree U.S. High Divi.. 0.00 % 0.38 %

+0.30 (+-0.10%)

N/A
GBF iShares Government/Credit.. 0.00 % 0.20 %

-0.07 (-0.10%)

N/A
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

-0.73 (-0.10%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.07 (+-0.10%)

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

-0.13 (-0.10%)

N/A
PPH VanEck Pharmaceutical ETF 0.00 % 0.36 %

-0.40 (-0.10%)

USD 0.69B
QLTA iShares Aaa - A Rated Cor.. 0.00 % 0.15 %

-0.06 (-0.10%)

USD 1.60B
NUBD Nuveen ESG U.S. Aggregate.. 0.00 % 0.20 %

-0.01 (-0.10%)

USD 0.40B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.17 (+-0.10%)

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
HUL-U:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.05 (+-0.10%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.05 (+-0.10%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
UXM.B:CA 0.00 % 0.67 %

N/A

N/A
HUL:CA 0.00 % 2.20 %

N/A

N/A
BVAL 0.00 % 0.65 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-9.20 (-0.10%)

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.10 (+-0.10%)

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.08 (+-0.10%)

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+6.00 (+-0.10%)

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+6.25 (+-0.10%)

N/A
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

-50.00 (-0.10%)

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+6.25 (+-0.10%)

USD 0.09B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

-3.00 (-0.10%)

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
HART IQ Healthy Hearts ETF 0.00 % 0.00 %

-0.10 (-0.10%)

USD 8.92M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.63% 70% C- 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.63% 70% C- 48% F
Trailing 12 Months  
Capital Gain 2.69% 60% D- 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.69% 60% D- 34% F
Trailing 5 Years  
Capital Gain -7.87% 67% D+ 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.87% 67% D+ 46% F
Average Annual (5 Year Horizon)  
Capital Gain -3.37% 22% F 20% F
Dividend Return -0.23% 22% F 21% F
Total Return 3.14% 56% F 64% D
Risk Return Profile  
Volatility (Standard Deviation) 18.86% 33% F 57% F
Risk Adjusted Return -1.20% 22% F 22% F
Market Capitalization 106.76B 29% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.